Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

The moving parts of orphan drug development

Tackling rare diseases requires high levels of cooperation, regulatory support and a determination to succeed

- PMLiVE

FDA gives early green light to Spectrum’s lymphoma drug

Beleodaq approved to treat rare cancer

- PMLiVE

Lucid wins med ed consultancy of the year

Second victory in a row at Communiqué Awards

Boehringer Ingelheim headquarters

Boehringer submits COPD combo in EU

Combines Spiriva and Striverdi

- PMLiVE

MSD’s Kate Tillett rewarded for healthcare comms excellence

Company's external affairs director wins at Communiqué 2014

- PMLiVE

Roche wins In-House Team of the Year at Communiqué Awards

"Brave and courageous" UK communications team picks up honour

- PMLiVE

Pegasus wins Consultancy of the Year at Communiqué 2014

Brighton-based comms agency praised for focus, authenticity and delivery

- PMLiVE

Liberation recognised at healthcare comms awards

Picks up Communiqué Small Consultancy or Health Team of the Year

- PMLiVE

Life Science Hub Wales names COO

Ian Barwick will help lead efforts to make Wales a key region for life sciences

- PMLiVE

Onyx launches women’s health blog

PR firm aims to understand women’s attitudes towards their health

- PMLiVE

France wants Avastin used in place of Lucentis

Government calls for off-label use of Roche drug in order to reduce spend on eye therapy

EU flag

EC sets out its pharma priorities

New strategy puts the industry at the heart of Europe’s economic growth prospects, saysEFPIA

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links